0001654954-20-000145 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 6th, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 6, 2020, between Edesa Biotech, Inc., a British Columbia corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CLASS A COMMON SHARE PURCHASE WARRANT EDESA BIOTECH, INC.Security Agreement • January 6th, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations
THIS CLASS A COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six (6) month anniversary of the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the third (3rd) anniversary of the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Edesa Biotech, Inc., a British Columbia corporation (the “Company”), up to _____ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common shares (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANT TO PURCHASE COMMON SHARES EDESA BIOTECH, INC.Purchase Warrant Agreement • January 6th, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, Brookline Capital Markets, a division of Arcadia Securities or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth (including the limitations set forth above), at any time on or after January 8, 2020 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the date of the Securities Purchase Agreement (the “Termination Date”) but not thereafter, to subscribe for and purchase from Edesa Biotech, Inc., a British Columbia corporation (the “Company”), up to 12,364 Common Shares (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
NON-BROKERED PRIVATE PLACEMENT OF UNITS SUBSCRIPTION AGREEMENT INSTRUCTIONSSubscription Agreement • January 6th, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations • Ontario